112 related articles for article (PubMed ID: 9741994)
1. Tetrofosmin thyroid scintigraphy.
Klain M; Cuocolo A; Salvatore M; Maurea S
Eur J Nucl Med; 1998 Jul; 25(7):816. PubMed ID: 9741994
[No Abstract] [Full Text] [Related]
2. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
Giordano A; Meduri G; Marozzi P; Rubini G; Burroni L; Cappagli M
Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-tetrofosmin scintigraphy, P-glycoprotein and lung cancer.
Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
J Nucl Med; 1998 Oct; 39(10):1830-1. PubMed ID: 9776299
[No Abstract] [Full Text] [Related]
4. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer: reply.
Fukushima K; Ishii K; Sakai E
Eur J Nucl Med; 1998 Jul; 25(7):816-8. PubMed ID: 9741995
[No Abstract] [Full Text] [Related]
6. [Various dynamics of Tc-99m-tetrofosmin and Tc-99m-MIBI in a parathyroid adenoma].
Nowak B; Sabri O; Hoff C; Reinartz P; Kleinhans E; Zimny M
Nuklearmedizin; 1999; 38(5):160-3. PubMed ID: 10488484
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer.
Derebek E
Eur J Nucl Med; 1998 Apr; 25(4):448. PubMed ID: 9643975
[No Abstract] [Full Text] [Related]
8. [The use of imaging modalities in patient with thyroid nodule: ultrasonography and radionuclide scintigraphy with new tracers].
Hod N; Strauss S; Horne T
Harefuah; 2001 May; 140(5):421-4. PubMed ID: 11419067
[No Abstract] [Full Text] [Related]
9. Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function.
Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1529-31. PubMed ID: 14579093
[TBL] [Abstract][Full Text] [Related]
10. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.
Ballinger JR
Cancer Biother Radiopharm; 2001 Feb; 16(1):1-7. PubMed ID: 11279792
[No Abstract] [Full Text] [Related]
11. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
12. Assessment of 99Tcm-tetrofosmin lung uptake: a modified method to avoid the contribution from high chest wall activity.
Heiba SI; Ziada G; Higazy E; Saleh M; Elgazzar AH
Nucl Med Commun; 1998 Sep; 19(9):859-66. PubMed ID: 10581592
[TBL] [Abstract][Full Text] [Related]
13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
14. Molecular breast imaging with gamma emitters.
Schillaci O; Spanu A; Danieli R; Madeddu G
Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):340-51. PubMed ID: 24322791
[TBL] [Abstract][Full Text] [Related]
15. Discordant washout of 99mTc sestamibi and 99mTc tetrofosmin in a patient with mediastinal seminoma.
Ishibashi M; Fujimoto K; Ohzono H; Fujii T; Koganemaru M; Hayabuchi N
Acta Oncol; 1998; 37(2):203-4. PubMed ID: 9636017
[No Abstract] [Full Text] [Related]
16. Monitoring therapy in breast cancer.
Buscombe JR
Nucl Med Commun; 2002 Jul; 23(7):619-24. PubMed ID: 12089483
[TBL] [Abstract][Full Text] [Related]
17. [Breast scintigraphy].
Prats E; Razola P; García López F; Dolores Abós M; Banzo J
Rev Esp Med Nucl; 2001 Feb; 20(1):47-70. PubMed ID: 11181333
[No Abstract] [Full Text] [Related]
18. Technetium-99m-tetrofosmin uptake in sarcoidosis stage I.
Tschabitscher D; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Molnar M; Dinges HP; Kroiss A; Lind P
J Nucl Med; 1997 Nov; 38(11):1786-7. PubMed ID: 9374356
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
20. The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporation.
Molteni SN; Seregni E; Botti C; Martinetti A; Ferrari L; Crippa F; Bombardieri E
Anticancer Res; 1999; 19(1A):255-9. PubMed ID: 10226551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
